These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24940647)

  • 1. AV block II in a toddler after ingestion of a single tablet fingolimod.
    Höjer J; Olsson E
    Clin Toxicol (Phila); 2014 Jul; 52(6):644. PubMed ID: 24940647
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed cardiac dysrhythmias after fingolimod administration.
    Rosini JM; Rajasimhan S; Fellows SE; Nomura JT
    Am J Emerg Med; 2015 Jul; 33(7):987.e1-3. PubMed ID: 25669873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism.
    Voon V; Saiva L; O'Kelly S; Keane D
    Eur J Clin Pharmacol; 2014 Mar; 70(3):373-5. PubMed ID: 24309839
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
    Széplaki G; Merkely B
    Ideggyogy Sz; 2012 Nov; 65(11-12):369-76. PubMed ID: 23289171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vagomimetic effects of fingolimod: physiology and clinical implications.
    Vanoli E; Pentimalli F; Botto G
    CNS Neurosci Ther; 2014 Jun; 20(6):496-502. PubMed ID: 24836740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fingolimod: cardiovascular deaths.
    Prescrire Int; 2012 Apr; 21(126):99. PubMed ID: 22515137
    [No Abstract]   [Full Text] [Related]  

  • 7. Fingolimod exacerbated affective psychosis?
    Fitzpatrick A; Clark SR; Newcombe R; Davis A; Baune BT
    Aust N Z J Psychiatry; 2013 Apr; 47(4):399-400. PubMed ID: 23042940
    [No Abstract]   [Full Text] [Related]  

  • 8. Fingolimod. Check cardiovascular status again on treatment resumption.
    Prescrire Int; 2014 Jan; 23(145):13. PubMed ID: 24516904
    [No Abstract]   [Full Text] [Related]  

  • 9. Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
    Rolf L; Muris AH; Damoiseaux J; van Daele M; Hupperts R
    Neurology; 2014 Mar; 82(11):1008-9. PubMed ID: 24523479
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
    Lysandropoulos AP; Benghiat F
    Mult Scler; 2013 Oct; 19(11):1551-2. PubMed ID: 23817558
    [No Abstract]   [Full Text] [Related]  

  • 11. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report.
    Conzett KB; Kolm I; Jelcic I; Kamarachev J; Dummer R; Braun R; French LE; Linnebank M; Hofbauer GF
    Arch Dermatol; 2011 Aug; 147(8):991-2. PubMed ID: 21844470
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed fingolimod-associated asystole.
    Espinosa PS; Berger JR
    Mult Scler; 2011 Nov; 17(11):1387-9. PubMed ID: 21652609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged and symptomatic bradycardia following a single dose of fingolimod.
    Faber H; Fischer HJ; Weber F
    Mult Scler; 2013 Jan; 19(1):126-8. PubMed ID: 22729989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden unexpected death on fingolimod.
    Lindsey JW; Haden-Pinneri K; Memon NB; Buja LM
    Mult Scler; 2012 Oct; 18(10):1507-8. PubMed ID: 22300970
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
    Gross CM; Baumgartner A; Rauer S; Stich O
    Neurology; 2012 Nov; 79(19):2006-7. PubMed ID: 23035074
    [No Abstract]   [Full Text] [Related]  

  • 16. Fingolimod for multiple sclerosis.
    Pelletier D; Hafler DA
    N Engl J Med; 2012 Jan; 366(4):339-47. PubMed ID: 22276823
    [No Abstract]   [Full Text] [Related]  

  • 17. Cystoid macular edema associated with fingolimod use for multiple sclerosis.
    Afshar AR; Fernandes JK; Patel RD; Ksiazek SM; Sheth VS; Reder AT; Hariprasad SM
    JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220
    [No Abstract]   [Full Text] [Related]  

  • 18. VZV encephalitis that developed in an immunized patient during fingolimod therapy.
    Issa NP; Hentati A
    Neurology; 2015 Jan; 84(1):99-100. PubMed ID: 25416038
    [No Abstract]   [Full Text] [Related]  

  • 19. Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis.
    Gallego-Pinazo R; España-Gregori E; Casanova B; Pardo-López D; Díaz-Llopis M
    J Neuroophthalmol; 2011 Sep; 31(3):292-3. PubMed ID: 21826025
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of fingolimod in relapsing-remitting multiple sclerosis.
    Sorensen PS
    Lancet Neurol; 2014 Jun; 13(6):526-7. PubMed ID: 24685277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.